Cancer Treatment Centers of America
Cancer Treatment Centers of America, now operating as City of Hope, is a private national oncology platform running five hospital campuses and seven outpatient centers across the U.S., delivering comprehensive personalized cancer treatment to individual patients across 100+ cancer types.
- Company typePrivate
- Founded1988
- HeadquartersBoca Raton, United States
- Headcount5,001–10,000
- GTM typeB2C
- OfferingServices
What Cancer Treatment Centers of America does
Cancer Treatment Centers of America, now operating under the City of Hope brand following a merger, is a private, for-profit national oncology care platform headquartered operationally at Duarte, California (with corporate registration tied to Boca Raton, Florida). The company operates five inpatient hospital campuses in Atlanta, Chicago, Duarte, Orange County, and Phoenix, supported by seven outpatient care centers across Arizona, Illinois, and Georgia. It was founded in 1988 and employs 5,001–10,000 people. City of Hope brings a 100+ year research legacy and is a founding member of the National Comprehensive Cancer Network (NCCN).
The platform delivers the full oncology care continuum across 100+ cancer types through dedicated disease-specific centers (Breast Cancer Center, GI Cancer Center, Lung Cancer Center) and treatment modules including chemotherapy, radiation therapy (external beam including IMRT/IGRT/TomoTherapy/proton therapy/SRS/SBRT, brachytherapy, systemic), surgical oncology (open, laparoscopic, robotic, cryosurgery), immunotherapy (checkpoint inhibitors, CAR T-cell, vaccines, cytokines), precision medicine, and theranostics (Pluvicto, radioactive iodine). Diagnostic capabilities span advanced imaging, genetic and genomic testing (BRCA1/2, MammaPrint, Oncotype DX), and laboratory services. Supportive care (nutritional, naturopathic, behavioral health, pain management, spiritual, survivorship) and the ASURE enhanced surgical recovery program provide whole-person wraparound services.
Revenue is generated through professional services for inpatient and outpatient cancer care, billed primarily through commercial insurance and most Medicare plans; pricing is not publicly disclosed and varies by plan and treatment regimen. The go-to-market motion is direct-to-consumer: patients self-refer via a 24/7 phone line (888-552-6760), website, or live chat, supported by insurance verification, physician referrals, telehealth, and an international patient services channel. Customers are individual cancer patients segmented by tumor type rather than institutional buyers. Leadership includes CEO Pat Basu, Founder/Chairman Richard J Stephenson, CFO Douglas Costa, CIO Jennifer Greenman, CMO Julian Schink, COO Pete Govorchin, and CMO Ken Chaplin.
Cancer Treatment Centers of America firmographics
Firmographics- Name
- Cancer Treatment Centers of America
- Legal name
- Cancer Treatment Centers of America
- Website
- https://cancercenter.com
- Company type
- Private
- Founded year
- 1988
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Cancer Treatment Centers of America, now operating as City of Hope, is a private national oncology platform running five hospital campuses and seven outpatient centers across the U.S., delivering comprehensive personalized cancer treatment to individual patients across 100+ cancer types.
- Ownership category
- akta.pro rank
Cancer Treatment Centers of America industry classification
Industry- Product category
- Oncology Care Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Offices of Physicians (62111), Ambulatory Health Care Services (621)
- SIC
- Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)
Keywords
Where Cancer Treatment Centers of America is headquartered
LocationHeadquarters
- HQ city
- Boca Raton
- HQ country
- United States
- HQ region
- North America
Offices12 records
Markets served
Cancer Treatment Centers of America business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Patient Care Services: Revenue generated from comprehensive cancer treatment services including inpatient hospital care, outpatient treatments, diagnostic procedures, surgical services, radiation therapy, chemotherapy, immunotherapy, and supportive care services at hospital campuses and outpatient care centers across multiple U.S. locations
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | Quote-based pricing - patient responsibility varies by insurance plan and treatment regimen |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels7 records
Cancer Treatment Centers of America product offering
Product offeringCore offering
Cancer Treatment Centers of America (CTCA), now operating under the City of Hope brand, provides comprehensive cancer diagnosis, treatment, and supportive care through a network of specialized cancer hospitals and outpatient care centers. Services span chemotherapy, radiation therapy, surgical oncology, immunotherapy, precision medicine, theranostics, diagnostic imaging, genetic and genomic testing, and supportive care, delivered by multidisciplinary teams under one roof.
Product overview
City of Hope (formerly Cancer Treatment Centers of America) is a unified cancer care platform comprising specialized cancer hospitals in Atlanta, Chicago, Duarte, Orange County, and Phoenix, supported by multiple Outpatient Care Centers. The organization offers a comprehensive suite of treatment modalities organized around dedicated cancer centers (Breast Cancer Center, GI Cancer Center, Lung Cancer Center) and treatment options including Chemotherapy, Radiation Therapy (external beam, internal, systemic), Surgical Oncology (including robotic surgery and ASURE recovery program), Immunotherapy (checkpoint inhibitors, CAR T-cell, vaccines), Precision Medicine, and Theranostics. Diagnostic capabilities span Genetic/Genomic Testing, Laboratory Tests (MammaPrint, Oncotype DX, CTC tests), and Imaging Services. Supportive Care Services include nutritional support, oncology rehabilitation, pain management, behavioral health, and survivorship support, all delivered through a multidisciplinary team approach under one roof.
Differentiator
Problem solved
Functional benefit
Brands
- City of Hope Cancer Treatment Centers: Cancer treatment hospitals and outpatient care centers
- Breast Cancer Center
- GI Cancer Center
- Lung Cancer Center
Products and services
- City of Hope Cancer Treatment Hospitals A network of specialized cancer hospitals providing comprehensive inpatient and outpatient cancer care across multiple U.S. locations (Atlanta, Chicago, Duarte, Orange County, Phoenix). Targeted at adult cancer patients requiring multidisciplinary treatment.
- Comprehensive Cancer Treatment Options Full spectrum of cancer treatment modalities including chemotherapy, radiation therapy, surgery, immunotherapy, targeted therapy, precision medicine, interventional oncology, and supportive care procedures for adult cancer patients.
- Immunotherapy Program Cancer immunotherapy treatments including checkpoint inhibitors (PD-1, CTLA-4), CAR T-cell therapy, cancer vaccines, cytokines, and oncolytic virus therapy for adult cancer patients.
- Chemotherapy Services Systemic chemotherapy treatments using alkylating agents, antimetabolites, antitumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and plant alkaloids, delivered in inpatient and outpatient settings.
- Radiation Therapy Radiation oncology services including external beam radiation therapy (IMRT, IGRT, TomoTherapy, proton therapy, SRS, SBRT), internal radiation therapy (brachytherapy), and systemic radiation therapy for adult cancer patients.
- Surgical Oncology Surgical cancer treatments including open surgery, minimally invasive laparoscopy, laser surgery, cryosurgery, robotic-assisted surgery, and reconstructive surgery for adult cancer patients.
- Breast Cancer Center Dedicated breast cancer treatment center offering diagnosis, staging, and treatment for all breast cancer types including early-stage, triple-negative, and inflammatory breast cancer. Located within each City of Hope hospital campus.
- GI Cancer Center Gastrointestinal cancer center specializing in colorectal cancer and other GI malignancies, with nutrition therapy and supportive care services. Located within each City of Hope hospital campus.
- Lung Cancer Center Dedicated lung cancer center offering diagnosis, staging, and treatment for NSCLC and SCLC with advanced genomic testing and immunotherapy options. Located within each City of Hope hospital campus.
- Prostate Cancer Treatment Prostate cancer treatment including 4D radiation therapy, hormone therapy, immunotherapy, and supportive care focused on quality-of-life maintenance for men diagnosed with prostate cancer.
- Precision Medicine Personalized cancer treatment using genetic and tumor marker testing to design targeted therapies based on individual tumor signatures.
- Advanced Surgical Recovery Program (ASURE) Enhanced recovery program combining pre-habilitation, nutrition, pain management with non-narcotic relievers, and physical activity within 24 hours post-surgery, for adult surgical oncology patients.
- Diagnostic Services Comprehensive cancer diagnostics including biopsy, imaging (CT, MRI, PET/CT, mammography, ultrasound, X-ray, nuclear medicine), laboratory tests, and genetic/genomic testing for adult patients.
- Genetic and Genomic Testing Advanced genomic testing of tumor DNA and genetic testing for inherited mutations (BRCA1/2) to identify treatment options and cancer risk for adult patients.
- Laboratory Tests Clinical laboratory testing including CellSearch circulating tumor cell tests, CBC tests, flow cytometry, MammaPrint/BluePrint, Oncotype DX, CEA, and tumor marker tests for adult patients.
- Supportive Care Services Whole-person supportive care including nutritional support, oncology rehabilitation, pain management, spiritual support, behavioral health, naturopathic support, and survivorship support for adult cancer patients and their families.
- Theranostics Cancer care combining diagnostics and treatment, including radioactive iodine therapy and Pluvicto for targeted cancer treatment in adult patients.
- Clinical Trials Access to clinical trials evaluating new drug development, technologies, and innovative treatment approaches for eligible adult cancer patients at City of Hope / CTCA facilities.
- Outpatient Care Centers Multiple outpatient care centers in Downtown Chicago, Gilbert, North Phoenix, North Shore, Paces Ferry, Prescott, and Scottsdale providing consultations, follow-up care, and outpatient treatments closer to patients' homes.
- Patient Portal Online patient portal for accessing medical records, scheduling, and communicating with the care team, available to City of Hope / CTCA patients.
Quantifiable outcome
- Five-year survival rate of 65% for colorectal cancer when detected early (before spread), increasing to 91% when detected before metastasis
- +2 more outcomes
Companies that use Cancer Treatment Centers of America
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles6 records
Cancer Treatment Centers of America technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Cancer Treatment Centers of America partnerships and signals
Strategic signalScale indicators3 records
Recent moves7 records
Expansion highlights5 records
Cancer Treatment Centers of America competitors and assessment
Company assessmentDirect peers
- MD Anderson Cancer Center: One of the world's largest dedicated cancer centers, providing comprehensive inpatient and outpatient oncology care, research, and clinical trials. Directly comparable as a specialty oncology hospital network with multidisciplinary, research-driven cancer care.
- Memorial Sloan Kettering Cancer Center: Premier specialty cancer hospital and research institution with multiple regional outpatient sites. Closely comparable to City of Hope/CTCA as a top-tier, research-driven oncology provider offering surgery, chemotherapy, radiation, immunotherapy, and precision medicine.
- Dana-Farber Cancer Institute: Specialty cancer hospital and research center with multidisciplinary oncology care and clinical trials. Directly comparable as a research-intensive, specialty cancer provider with similar mission and care model.
- Moffitt Cancer Center: NCI-designated Comprehensive Cancer Center offering inpatient and outpatient oncology services, research, and clinical trials. Comparable as a specialty cancer hospital network with multidisciplinary, research-driven cancer care.
- Fred Hutchinson Cancer Center: Research-driven specialty cancer center with clinical care, bone marrow transplantation, and immunotherapy programs. Directly comparable as a research-intensive oncology specialty provider.
Broad incumbents
- Mayo Clinic: Large, multispecialty academic health system with a major oncology program across multiple campuses. Comparable as a destination cancer care provider with research, complex care, and multidisciplinary teams, though oncology is part of a broader portfolio.
- Cleveland Clinic: Multispecialty health system with a strong cancer institute and multiple regional hospitals. Comparable as a brand-led, geographically distributed provider of complex oncology care within a broader clinical portfolio.
- HCA Healthcare: Largest for-profit hospital operator in the U.S., with significant oncology service lines across a national footprint. Comparable as a multi-state, for-profit provider of complex inpatient and outpatient cancer care, though within a diversified hospital portfolio.
- Tenet Healthcare: For-profit hospital system operating specialty and acute care hospitals with oncology service lines. Comparable as a multi-state for-profit provider of complex inpatient and outpatient cancer care within a diversified portfolio.
Emerging players
- U.S. Oncology Network (McKesson): Large network of community-based oncology practices affiliated through McKesson, providing medical oncology, infusion, and radiation services. Comparable as a multi-site oncology delivery platform, though community-focused rather than hospital-based.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Cancer Treatment Centers of America social profiles
Digital presenceCancer Treatment Centers of America financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cancer Treatment Centers of America leadership team
Management profileNumber of profiles
Profiles15 records
Cancer Treatment Centers of America funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cancer Treatment Centers of America M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cancer Treatment Centers of America
What does Cancer Treatment Centers of America do?
Cancer Treatment Centers of America (CTCA), now operating under the City of Hope brand, provides comprehensive cancer diagnosis, treatment, and supportive care through a network of specialized cancer hospitals and outpatient care centers. Services span chemotherapy, radiation therapy, surgical oncology, immunotherapy, precision medicine, theranostics, diagnostic imaging, genetic and genomic testing, and supportive care, delivered by multidisciplinary teams under one roof.
Is Cancer Treatment Centers of America a public or private company?
Cancer Treatment Centers of America is a private company. It is classified as corporate owned and is currently operating.
When was Cancer Treatment Centers of America founded?
Cancer Treatment Centers of America was founded in 1988. It employs 5,001 to 10,000 people.
Where is Cancer Treatment Centers of America based?
Cancer Treatment Centers of America is headquartered in Boca Raton, United States, in the North America region.
How does Cancer Treatment Centers of America make money?
One revenue line is on record: patient Care Services.
Who are Cancer Treatment Centers of America's main competitors?
Direct peers on record are MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Moffitt Cancer Center and Fred Hutchinson Cancer Center. Broad incumbents are Mayo Clinic, Cleveland Clinic, HCA Healthcare and Tenet Healthcare. U.S. Oncology Network (McKesson) is listed as an emerging player.
Does Cancer Treatment Centers of America have an API?
No public API is recorded for Cancer Treatment Centers of America.
What industry is Cancer Treatment Centers of America in?
Cancer Treatment Centers of America's product category is Oncology Care Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622310 and its SIC code is 8060.